Long-Term Treatments of Anxiety Disorders is a celebration of the important advances made in the treatment of anxiety disorders since the 1970s. It is a unique resource that will enable the reader, regardless of theoretical or professional orientation, to develop an updated and balanced perspective on the psychological and pharmacological approaches to treating these disorders. The volume provides a critical appraisal of the long-term treatment of anxiety disorders and offers state-of-the-art recommendations for planning and implementing specific maintenance treatment strategies to ensure favorable long-term outcomes. Four general chapters present an overview of the epidemiology and natural course of the anxiety disorders, outline the basic mechanisms active in pharmacological and cognitive-behavioral treatments of these disorders, and extract lessons from the more advanced long-term treatment research literature on depressive disorders. The remaining 10 chapters are devoted to specific disorders and/or treatment modalities.
Students who need to recognize the specific merits of psychological and pharmacological treatments of the anxiety disorders, clinicians who apply empirically validated treatment principles in their practices, and clinical researchers who recognize the challenge of developing a more robust foundation for optimal treatments all will find Long-Term Treatments of Anxiety Disorders to be an informative, stimulating, and practical resource.
Sprache
Verlagsort
Verlagsgruppe
American Psychiatric Association Publishing
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
Maße
Höhe: 229 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-88048-656-9 (9780880486569)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Matig R. Mavissakalian, M.D., is Professor in the Department of Psychiatry and Director of the Phobia and Anxiety Disorders Clinic at Ohio State University College of Medicine in Columbus, Ohio. Robert F. Prien, Ph.D., is Chief of the Clinical Treatment Branch at the National Institute of Mental Health in Rockville, Maryland.
Natural course of anxiety disorders. Mechanisms of action of cognitive-behavior treatment of anxiety disorders. Pharmacology for anxiety disorders. Depression: longitudinal therapeutic studies. Long-term effects of behavior therapy. Psychosocial treatment for generalized anxiety disorder. Pharmacological treatment for generalized anxiety disorder. Psychological treatments for panic disorder and panic disorder with agoraphobia. Benzodiazepine treatment for panic disorder. Antidepressant medications for panic disorder. Psychological treatment for obsessive-compulsive disorder. Pharmacological treatment for obsessive-compulsive disorder. Behavioral and pharmacological treatment for social phobia. Posttraumatic stress disorder: issues in short- and long-term treatment. Index.